Glucose monitor maker Dexcom beats quarterly sales estimates, …

Oct 24 (Reuters) - Medical device maker Dexcom (DXCM.O) beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose …

CouponFollow Extension

25%
OFF

Dexcom Posts Highest-ever Quarterly Revenues After 25% Growth

1 week from now

Jul 28, 2023 · Those new additions were helped along by the CEO’s report that in the U.S. alone, about 8,000 doctors are now writing prescriptions for Dexcom’s continuous glucose monitors …

fiercebiotech.com

1%
OFF

DexCom (DXCM) Beats On Q3 Earnings, Raises Sales Outlook

1 week from now

Oct 27, 2023 · DexCom, Inc. DXCM reported third-quarter 2023 adjusted earnings per share (EPS) of 50 cents, which beat the Zacks Consensus Estimate of 22 cents by 47.1%. The …

yahoo.com

7%
OFF

Dexcom's Profit Beats Estimates On Strong Glucose Monitor Demand

1 week from now

Apr 25, 2024 · Dexcom beat Wall Street expectations for first-quarter profit on Thursday, helped by strong demand for a new version of its continuous glucose monitors, but its shares slid 7% …

yahoo.com

27%
OFF

Dexcom Beats Profit Estimates On Strong Demand For Glucose Monitors

1 week from now

Feb 8, 2024 · Glucose monitor maker Dexcom beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems. Sales of the monitors, which compete with Abbott's FreeStyle Libre devices, rose 27% to $1.03 billion in the three months ended Dec. 31, compared with estimates of $1.02 billion, according …

yahoo.com

FAQs about Glucose monitor maker Dexcom beats quarterly sales estimates, … Coupon?

Did Dexcom beat Wall Street estimates for third-quarter revenue & profit?

Oct 24 (Reuters) - Medical device maker Dexcom (DXCM.O) beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and improved sales in international markets. ...

Did Dexcom beat analyst estimates for fourth-quarter earnings?

Feb 8 (Reuters) - Glucose monitor maker Dexcom (DXCM.O) beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems. ...

Why did Dexcom (DXCM) raise its revenue forecast?

REUTERS/Hannah Beier/File Photo Purchase Licensing Rights Oct 26 (Reuters) - Medical device maker Dexcom (DXCM.O) on Thursday raised its annual revenue forecast and beat quarterly estimates on strong demand for its continuous glucose monitoring (CGM) devices, sending its shares more than 14% higher in extended trading. ...

How did Dexcom perform in Q4?

Excluding items, Dexcom posted a profit of 50 cents per share in the fourth quarter, above analysts' average estimate of 43 cents. Still, Dexcom only reiterated its 2024 forecast of $4.15-$4.35 billion, given in January. Analysts are expecting annual sales of $4.33 billion. Shares of the company were down 1.5% at $125.1 in after-market trading. ...

How much revenue does Dexcom make?

Dexcom's total revenue rose 24% to $921 million for the three months ended March 31, beating analysts' average estimate of $909.24 million, according to LSEG data. The company raised the lower end of its 2024 revenue forecast by $50 million, and now expects it to be between $4.20 billion and $4.35 billion. ...

How did glucose monitor's revenue grow?

Total revenues grew 27% (26% on an organic basis) to $975 million on a year-over-year basis and beat the Zacks Consensus Estimate by 4%. Strong revenue growth was driven by rising volumes on the back of increasing global awareness of the benefits of real-time Continuous Glucose Monitoring and strong customer additions. ...